BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 15480901)

  • 1. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T; Harada T; Ko M; Yamato M; Takahara K; Yamauchi A
    Clin Exp Nephrol; 2003 Sep; 7(3):210-4. PubMed ID: 14586717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of corticosteroid and warfarin therapy in IgA nephropathy with crescent formation: preliminary trial.
    Kanno Y; Witt M; Okada H; Nemoto H; Sugahara S; Nakamoto H; Suzuki H
    Clin Exp Nephrol; 2003 Mar; 7(1):48-51. PubMed ID: 14586743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steroid therapy in IgA nephropathy: a prospective pilot study in moderate proteinuric cases.
    Kobayashi Y; Fujii K; Hiki Y; Tateno S
    Q J Med; 1986 Oct; 61(234):935-43. PubMed ID: 3628707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of steroid therapy in 275 adult patients with IgA nephropathy determined using a histological scoring system and degree of proteinuria.
    Suzuki S; Joh K
    Clin Exp Nephrol; 2004 Jun; 8(2):109-16. PubMed ID: 15235927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of poor outcomes in steroid therapy for immunoglobulin A nephropathy.
    Shimizu A; Takei T; Uchida K; Tsuchiya K; Nitta K
    Nephrology (Carlton); 2009 Aug; 14(5):521-6. PubMed ID: 19674320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual renin-angiotensin system blockade plus oral methylprednisone for the treatment of proteinuria in IgA nephropathy.
    Trimarchi H; Muryan A; Young P; Forrester M; Iotti A; Pereyra H; Lombi F; Seminario O; Alonso M; Iotti R
    Medicina (B Aires); 2007; 67(5):445-50. PubMed ID: 18051227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C; Torres DD; Rossini M; Pesce F; Schena FP
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of steroid therapy in IgA nephropathy].
    Ohashi T; Shimokawahara H; Fukumoto M; Azuma K; Uchida Y; Tokuda Y; Ito H; Yasumoto Y; Yamashita W; Harada R
    Fukuoka Igaku Zasshi; 1992 May; 83(5):209-15. PubMed ID: 1612550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathologic findings relevant to disappearance or relapse of proteinuria following corticosteroid treatment in IgA nephropathy patients with proteinuria of 0.5 to 2.0 g/day.
    Suzuki T; Yamamoto T; Ohura M; Fujigaki Y; Yonemura K; Kimura M; Hishida A
    Clin Exp Nephrol; 2004 Sep; 8(3):243-9. PubMed ID: 15480902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can immunosuppressive drugs slow the progression of IgA nephropathy?
    Goumenos D; Ahuja M; Shortland JR; Brown CB
    Nephrol Dial Transplant; 1995; 10(7):1173-81. PubMed ID: 7478120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J; Zhang H; Chen Y; Li G; Jiang L; Singh AK; Wang H
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteinuria-reducing effects of tonsillectomy alone in IgA nephropathy recurring after kidney transplantation.
    Kennoki T; Ishida H; Yamaguchi Y; Tanabe K
    Transplantation; 2009 Oct; 88(7):935-41. PubMed ID: 19935466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?
    Lai KN; Ho CP; Chan KW; Yan KW; Lai FM; Vallance-Owen J
    Q J Med; 1985 Oct; 57(222):677-88. PubMed ID: 4080957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Corticosteroid therapy in patients with IgA nephropathy and impaired renal function.
    Tamura S; Ueki K; Ideura H; Tsukada Y; Maezawa A; Kawai H; Wakamatsu R; Yano S; Nojima Y; Naruse T
    Clin Nephrol; 2001 Mar; 55(3):192-5. PubMed ID: 11316238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Point of no return (PNR)" in progressive IgA nephropathy: significance of blood pressure and proteinuria management up to PNR.
    Komatsu H; Fujimoto S; Sato Y; Hara S; Yamada K; Morita S; Eto T
    J Nephrol; 2005; 18(6):690-5. PubMed ID: 16358226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term administration of cyclosporine A in patients with IgA nephropathy].
    Chábová V; Tesar V; Zabka J; Rychlík I; Merta M; Jirsa M; Stejskalová A; Stejskal J
    Cas Lek Cesk; 1996 Dec; 135(24):803-6. PubMed ID: 9072300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.